269 related articles for article (PubMed ID: 25182363)
1. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
Wang X; Qian Y; Liu B; Cao L; Fan Y; Zhang JJ; Yu Y
Clin Radiol; 2014 Nov; 69(11):1165-70. PubMed ID: 25182363
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
3. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
[TBL] [Abstract][Full Text] [Related]
5. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
Maas MC; Fütterer JJ; Scheenen TW
Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
[TBL] [Abstract][Full Text] [Related]
9. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?
Metens T; Miranda D; Absil J; Matos C
Eur Radiol; 2012 Mar; 22(3):703-9. PubMed ID: 21971824
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
Liu X; Zhou L; Peng W; Wang C; Wang H
Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
[TBL] [Abstract][Full Text] [Related]
11. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
[TBL] [Abstract][Full Text] [Related]
13. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
Park SY; Kim CK; Park BK; Kwon GY
AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
16. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
Rosenkrantz AB; Khalef V; Xu W; Babb JS; Taneja SS; Doshi AM
Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
[TBL] [Abstract][Full Text] [Related]
17. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
19. High-resolution diffusion-weighted imaging of the prostate.
Medved M; Soylu-Boy FN; Karademir I; Sethi I; Yousuf A; Karczmar GS; Oto A
AJR Am J Roentgenol; 2014 Jul; 203(1):85-90. PubMed ID: 24951199
[TBL] [Abstract][Full Text] [Related]
20. High b-value diffusion-weighted MR imaging of normal brain at 3T.
Cihangiroglu M; Uluğ AM; Firat Z; Bayram A; Kovanlikaya A; Kovanlikaya I
Eur J Radiol; 2009 Mar; 69(3):454-8. PubMed ID: 18162352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
